Medios AG operates as a leading Specialty Pharma company, focusing on the supply of specialized pharmaceutical products and patient-specific therapies. Headquartered in Berlin, Germany, the company serves medical professionals, pharmacies, and pharmaceutical clients through two core segments: Pharmaceutical Supply, which provides treatments for oncology, neurology, autoimmunology, and other complex conditions, and Patient-Specific Therapies, compounding customized medications such as cytostatic infusions, antibody therapies, and parenteral nutrition solutions. As a pioneer in its field, Medios AG combines regulatory expertise with advanced compounding capabilities to address niche therapeutic needs, ensuring tailored treatments for individual patients. The company, founded in 2016, has grown into a key player in the German pharmaceutical market, emphasizing sustainability and compliance while supporting clinical studies and specialized care providers.